Clinical Trial Update: Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating three dosing schedules of CUE-101 given before surgery or definitive chemoradiation in patients with locally advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• CUE-101

Snippet

Sponsor: Washington University School of Medicine | Conditions: Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING